Clover Health

Earnings next week

$PLTR (+6,35 %)

$SMCI

$CELH

$ARM (-2,66 %)

$CLF (-0,33 %)

$AMC

$QCOM (+2,48 %)

$DKNG (+1,07 %)

$HIMS (-1,68 %)

$ELF (-0,44 %)

$ANET

$CLOV (+0,65 %)

$SQ (+1,31 %)

$APP (+5,4 %)

$VST (+1,56 %)

$NVO (-18,32 %)

$RIVN (+5,16 %)

$DVN (-0,03 %)

$U (+0,33 %)

$WYNN (-0,23 %)

$CVS (+0,57 %)

$CEG

$TTD (-2,1 %)

$MRNA (-1,12 %)

$$BRK.A (+0,54 %) (Saturday)

$CDE (+0,18 %)

$AFRM (+3,63 %)

$MELI (+2,5 %)

$FTNT (+1,49 %)

$PINS

$ABNB (+3,68 %)

$ABX (+0,54 %)

$HL (+1,26 %)

$MAR

$IONQ

$NET (+2,17 %)

$AXON (+1,43 %)

$ALB (-0,38 %)

$DOCS (+9,8 %)

$WOLF (+0,15 %)

$BROS

$PAAS (+0,1 %)

$DDOG (+1,55 %)

$LCID (+12,2 %)

$TOST (+3,6 %)

$LUMN (-1,89 %)

$MLCO (-1,67 %)

$DOCN (+0,12 %)

$ALAB

$ACB (+2,51 %)

$CLOV (+0,65 %) was unfortunately traded as a meme stock in the forums for a long time. But does that mean you can't invest? No!

Clover Health is a US company that offers Medicare Advantage plans and uses data and technology to improve healthcare for seniors. It focuses on patient-centered, cost-effective care.

The company is now profitable and there are many positive prospects on the horizon:

- Currently a CMS rating of 3.5, which is expected to be set to 4 in the near future

- It is assumed that Clover will offer its software as a SaaS model

- In general, demographic change is expected to increase the number of senior citizens in the USA (current retirement of baby boomers)

- Compared to its competitors, Clover is hot-as-hot cheap with just under one billion market capitalization vs. $UNH (+1,64 %) with over 500 billion and over 40 billion of $HUM (-2,08 %) . This alone shows what potential Clover still has.

I have a large position with an average purchase price of €1.50 and am currently up 70% and am looking forward to further upside.

Who else is invested in Clover and why?

Clover seems to be making a breakthrough, thanks in part to the Reddit offensive. When NYC opens, there will certainly be a lot of pressure again. Since yesterday almost 20% forecasts of analysts stand at 40 to 50 usd. Who is all in on Clover?

Clover wants to optimize the American healthcare system. A market with a lot of potential when you consider that the average American has an average life expectancy of 2 years less and 10-15% higher probability of suffering from up to 2 chronic diseases.

Investor Presentation:

https://investors.cloverhealth.com/static-files/8947bb5e-eb8d-4aa5-9c11-186c518d7676